Metrics to compare | NNNN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNNNNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 67.9x | 19.4x | −0.4x | |
PEG Ratio | 0.42 | 0.36 | 0.00 | |
Price/Book | 14.4x | 3.0x | 2.6x | |
Price / LTM Sales | 50.3x | 2.7x | 3.0x | |
Upside (Analyst Target) | - | 51.5% | 56.0% | |
Fair Value Upside | Unlock | 7.0% | 9.1% | Unlock |
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.